| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 04/20/2005 | EP1523312A1 Use of a rhein in a therapeutic treatment requiring a rise in the rate of heme oxygenase |
| 04/20/2005 | EP1443921B1 Production of pure stereoisomers of tricyclo-[5.2.1.0(2.6)]-dec-9-yl-xanthate esters and their use as medicaments |
| 04/20/2005 | EP1373249B1 Imidazolidine derivatives, their preparation, and their use as antiinflamatory agent |
| 04/20/2005 | EP1307425B1 Novel n-(2-phenyl-3-aminopropyl)naphtamides |
| 04/20/2005 | EP1252158B1 Nicotinamide benzofused-heterocyclyl derivatives useful as selective inhibitors of pde4 isozymes |
| 04/20/2005 | EP1129077B1 Fluorinated 3,4-dihydroquinoline derivatives used as nos inhibitors |
| 04/20/2005 | EP1001685B1 Nutritional compositions containing methionine |
| 04/20/2005 | EP0805859B1 A chemokine receptor able to bind to mcp-1, mip-1 alpha and/or rantes. its uses |
| 04/20/2005 | CN1608127A Methods for the production of 3-O-deactivated-4'-monophosphoryl lipid A(3D-MLA) |
| 04/20/2005 | CN1608069A Selective androgen receptor modulators and methods for their identification, design and use |
| 04/20/2005 | CN1608067A Pyrrolopyrimidines as phosphodiesterase vii inhibitors |
| 04/20/2005 | CN1608064A Novel compounds |
| 04/20/2005 | CN1607960A Glycoprotein compositions |
| 04/20/2005 | CN1607959A Human polypeptides causing or leading to the killing of cells including lymphoid tumor cells |
| 04/20/2005 | CN1607932A Methods for improving the aesthetic appearance of skin |
| 04/20/2005 | CN1607209A Poly thymosin-alpha 1, its composition, its preparation method and application |
| 04/20/2005 | CN1607005A Soluble lymphotoxin- beta receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological disease |
| 04/20/2005 | CN1606987A Allergy-resistant constituent |
| 04/20/2005 | CN1197966C Modulators of TNF receptor associated factor (TRAF), their preparation and use |
| 04/20/2005 | CN1197961C BHV-1 gene-deleted virus vaccine |
| 04/20/2005 | CN1197898C Nucleic compound and production method thereof, and its use in the preparation of immune formulation |
| 04/20/2005 | CN1197867C Application of cinidium general coumarin as psoriasis treating medicine |
| 04/20/2005 | CN1197849C 2, 3, 4, 5-tetrahydro-1H-[1, 4] benzodiazepine-3-hydroxamic acid as matrix metalloproteinase inhibitors |
| 04/20/2005 | CN1197620C Use of immidazoquinolinamines as adjuvants in DNA vaccination |
| 04/20/2005 | CN1197619C Biological therapy adjuvant originated from animal Chinese medicine |
| 04/20/2005 | CN1197618C Mutant cholera holotoxin as an adjuvant |
| 04/20/2005 | CN1197617C Fish serine proteinases and their pharmaceutical and cosmetic use |
| 04/20/2005 | CN1197606C Drug and preparation method for improvement of organism immunity |
| 04/20/2005 | CN1197575C Cetirizing hydrochloride cataplasm preparation |
| 04/20/2005 | CN1197541C Two chamber cartridge for atomizers |
| 04/19/2005 | US6881857 Tricyclic diterpene derivatives |
| 04/19/2005 | US6881854 Conjugated unsaturated glyceride mixtures and a method for producing the same |
| 04/19/2005 | US6881755 N-(2-aryl-propionyl)-sulfonamides and pharmaceutical preparations containing them |
| 04/19/2005 | US6881754 Adamantane derivatives |
| 04/19/2005 | US6881730 Steroid compounds with a c17-alkyl side chain and an aromatic a-ring for use in therapy |
| 04/19/2005 | US6881564 Enzymatic peptide comprising modified asparaginic residues for treatment of tumors, infection, liver and autoimmune disorders |
| 04/19/2005 | US6881552 Human protease associated proteins |
| 04/19/2005 | US6881411 Method of stimulating an immune response by administration of host organisms that express intimin alone or as a fusion protein with one or more other antigens |
| 04/19/2005 | US6881406 Administering an effective amount of a Chemokine receptor (CCR4) modulating agent, in a dose effective to modulate trafficking of systemic memmory T cells |
| 04/19/2005 | CA2334155C Cyclic boroproline compounds |
| 04/14/2005 | WO2005033339A1 Human toll-like receptor 3 gene polymorphism as marker for inherited factor of allergic disease and utilization of the same |
| 04/14/2005 | WO2005033145A1 Antibodies to nik, their preparation and use |
| 04/14/2005 | WO2005033089A1 Salt of 6-(1, 3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoic acid with n, n-dimethyl-imidodicarbonimidic diamide |
| 04/14/2005 | WO2005032589A1 Prevention and treatment for gvhd |
| 04/14/2005 | WO2005032568A1 Immunopotentiator, antiulcer agent and processed foods comprising fermented soybean product and process for producing fermented soybean product |
| 04/14/2005 | WO2005032484A2 Alkoxy substituted imidazoquinolines |
| 04/14/2005 | WO2005032462A2 Glucocerebroside treatment of disease |
| 04/14/2005 | WO2005018663A8 G-csf derivative for inducing immunological tolerance |
| 04/14/2005 | WO2005002512A3 Immunotherapeutic vaccine strategy |
| 04/14/2005 | WO2003063573A3 Method for treating diseases with omega interferon |
| 04/14/2005 | WO2003027228A3 Receptors and membrane-associated proteins |
| 04/14/2005 | WO2003015712A3 Methods for preparing compositions comprising heat shock proteins or alpha-2-macroglobulin |
| 04/14/2005 | US20050080118 Pharmaceuticals for the treatment of rejection reactions in organ transplantations |
| 04/14/2005 | US20050080107 Inhibitor of phosphodiesterase enzyme, 2-(4-(3-cyclopentyloxy-4-difluoromethoxyphenyl)-4-cyanopiperidin-1-yl)acetic acid monohydrate; treating inflammatory diseases, diabetics, allergic diseases, autoimmune diseases, ocular diseases, osteoporosis, Parkinson's disease, dementia; chemical intermediates |
| 04/14/2005 | US20050080097 5-[1-(hydroxymethyl)propyl]amino-7-benzylamino-3-isopropyl(methyl, ethyl)pyrazolo[4,3-d]pyrimidine for inhibiting cell proliferation, cancer, or psoriasis, rheumatoid arthritis, lupus, diabetes, multiple sclerosis, restenosis, polycystic kidney disease, graft rejection, and neurodegerative diseases |
| 04/14/2005 | US20050080067 Omega aminoalkylamides of R-2 aryl propionic acids as inhibitors of the chemotaxis of polymorphonucleate and mononucleate cells |
| 04/14/2005 | US20050080010 Suppression of immune response via inhibition of cathepsin S |
| 04/14/2005 | US20050080006 Apo2L/TRAIL formulations including lyophilized and crystal compositions; may be used in inducing apoptosis in mammalian cells including cancer cells by exposing mammalian cells to an effective amount of an Apo-2 ligand formulation described herein |
| 04/14/2005 | US20050079575 Human receptor molecules |
| 04/14/2005 | US20050079572 Expression vector comprising nuclelotide sequences coding brain acid soluble protein 1 (BASP1) for use in prevention and treatment of infection, cell proliferative, inflammatory and autoimmune disorders; gene therapy; immunotherapeutics |
| 04/14/2005 | US20050079538 polynucleotides which identify and encode human secreted proteins (SECP); expression vectors, host cells, antibodies, agonists, and antagonists; drug screening; anticarcinogenic agents |
| 04/14/2005 | US20050079503 Peptide comprising zinc binding of ubiquination protein for use as tool in identifying modulators for treatment and prevention of inflammation, reproductive and cell proliferation disorders |
| 04/14/2005 | US20050079502 Transplant rejection suppressor |
| 04/14/2005 | US20050079186 Therapeutic vaccine peptide complex for preventing and treating disorders in mammals |
| 04/14/2005 | US20050079176 Treating stress response with chemokine receptor ccr5 modulators |
| 04/14/2005 | US20050079136 Therapy for pain, appetite inttensifiers, multiple sclerosis and asthma; drug delivery |
| 04/14/2005 | DE10343365A1 Pharmazeutische Formulierungen von Xanthogenaten und Hemmstoffen der viralen Nukleinsäurereplikation Pharmaceutical formulations of xanthates and inhibitors of viral nucleic acid replication |
| 04/14/2005 | CA2541535A1 Antibodies to nik, their preparation and use |
| 04/14/2005 | CA2541006A1 Tim-3 polypeptides |
| 04/14/2005 | CA2540672A1 Educated nkt cells and their uses in the treatment of immune-related disorders |
| 04/14/2005 | CA2540666A1 Glucocerebroside treatment of disease |
| 04/14/2005 | CA2540521A1 Anti-nik antibodies and uses thereof |
| 04/13/2005 | EP1522591A2 Transgenically produced non-secreted proteins |
| 04/13/2005 | EP1522590A1 Methods for producing modified glycoproteins |
| 04/13/2005 | EP1522304A2 Compositions containing avenanthramides from extract of oats |
| 04/13/2005 | EP1521839A1 Methods of making viral particles having a modified cell binding activity and uses thereof |
| 04/13/2005 | EP1521828A2 Production of polyketides |
| 04/13/2005 | EP1521824A2 Nucleic acid-associated proteins |
| 04/13/2005 | EP1521822A2 Protein modification and maintenance molecules |
| 04/13/2005 | EP1521779A1 Compounds that bind to the interferon-gamma, preparation method thereof and medicaments containing same |
| 04/13/2005 | EP1521764A2 New compounds, compositions and methods for treatment of inflammatory diseases and conditions |
| 04/13/2005 | EP1521763A2 Novel nonsteroidal anti-inflammatory substances, compositions and methods for their use |
| 04/13/2005 | EP1521744A1 Arylsulphonamide derivatives and use thereof as b1 bradykinin receptor antagonists |
| 04/13/2005 | EP1521740A2 Probucol derivatives |
| 04/13/2005 | EP1521733A1 Modulators of the glucocorticoid receptor |
| 04/13/2005 | EP1521588A2 Use of alanyl-aminopeptidase inhibitors and pharmaceutical compositions containing said inhibitors |
| 04/13/2005 | EP1521585A1 Immunostimulation by chemically modified rna |
| 04/13/2005 | EP1521577A1 Methods of using isothiazole derivatives to treat cancer or inflammation |
| 04/13/2005 | EP1366050B1 Condensed pyrazindione derivatives as pde inhibitors |
| 04/13/2005 | EP1347787B1 Use of dexpanthenol in contact lens care compositions |
| 04/13/2005 | EP1289955B1 Piperidines for use as orexin receptor antagonists |
| 04/13/2005 | EP1257270B1 A method for synthesizing leflunomide |
| 04/13/2005 | EP0930893B1 Immunostimulatory polynucleotide/immunomodulatory molecule conjugates |
| 04/13/2005 | CN1606568A Process for the purification and/or isolation of biologically active granulocyte colony stimulating factor |
| 04/13/2005 | CN1606563A Use of glycosides of mono- and diacylglycerol as anti-inflammatory agents |
| 04/13/2005 | CN1606556A Triazolo-quinolin derivatives useful as adenosine receptor ligands |
| 04/13/2005 | CN1606555A Imidazoquinoline derivatives |
| 04/13/2005 | CN1606554A Beta-lactamyl vasopressin v1aantagonists |
| 04/13/2005 | CN1606463A Methods of treating bacterial infections in dogs and cats |
| 04/13/2005 | CN1606456A Restricted expression lentiviral vectors |